Immunome Inc Annual Shareholders Meeting Transcript
Good afternoon. I am Purnanand Sarma President, Chief Executive Officer, and the Director of the Immunome, Inc. I have been appointed Chairman of this meeting. I would like to welcome you and express the thanks of the Board and management for your attendance today. I now call the meeting to order.
To start, I would like to introduce the directors and [executive] officers of the Immunome present at this meeting. In addition to myself, the directors attending are Mike Rapp, our Chairman; Richard Baron; John LaMattina; Michael Lefenfeld; Phil Wagenheim; and Franklyn Prendergast. Also in attendance, today, is Dennis Giesing, our Chief Development Officer; Corleen Roche, our Chief Financial Officer; Matthew Robinson, our Chief Technology Officer; and Sandra Stoneman, our Chief Legal Officer.
Attending today are representatives of Ernst & Young LLP, the company's independent registered public accounting firm, Barry Shapiro with Broadridge Investor Communications Solutions, Inc., has been appointed as the Inspector of Elections
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
